Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann H Rux

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Transfusion|October 28, 2010
Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosisYvette C Tanhehco, Ann H Rux, Bruce S Sachais
Blood|December 14, 2004
Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent mannerGuangyao Yu, Ann H Rux, Peihong Ma, et al.
Blood|June 2, 2007
The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flowPing Zhang, Weilan Pan, Ann H Rux, et al.
Virology|May 16, 2002
Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3bAnn H Rux, Huan Lou, John D Lambris, et al.
Thrombosis and Haemostasis|November 15, 2007
Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- miceBruce S Sachais, Tiffany Turrentine, Jennine M Dawicki McKenna, et al.
Journal of Virology|July 30, 2003
Function of herpes simplex virus type 1 gD mutants with different receptor-binding affinities in virus entry and fusionRichard S B Milne, Sheri L Hanna, Ann H Rux, et al.
Blood|July 26, 2003
The kringle stabilizes urokinase binding to the urokinase receptorKhalil Bdeir, Alice Kuo, Bruce S Sachais, et al.
Blood|March 29, 2012
Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopeniaBruce S Sachais, Ann H Rux, Douglas B Cines, et al.
AIDS Research and Human Retroviruses|February 6, 2016
Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral AttachmentZahra F Parker, Ann H Rux, Amber M Riblett, et al.
The Journal of Biological Chemistry|October 8, 2013
Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4Rustem I Litvinov, Serge V Yarovoi, Lubica Rauova, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Transfusion|October 28, 2010
Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosisYvette C Tanhehco, Ann H Rux, Bruce S Sachais
Blood|December 14, 2004
Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent mannerGuangyao Yu, Ann H Rux, Peihong Ma, et al.
Blood|June 2, 2007
The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flowPing Zhang, Weilan Pan, Ann H Rux, et al.
Virology|May 16, 2002
Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3bAnn H Rux, Huan Lou, John D Lambris, et al.
Thrombosis and Haemostasis|November 15, 2007
Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- miceBruce S Sachais, Tiffany Turrentine, Jennine M Dawicki McKenna, et al.
Journal of Virology|July 30, 2003
Function of herpes simplex virus type 1 gD mutants with different receptor-binding affinities in virus entry and fusionRichard S B Milne, Sheri L Hanna, Ann H Rux, et al.
Blood|July 26, 2003
The kringle stabilizes urokinase binding to the urokinase receptorKhalil Bdeir, Alice Kuo, Bruce S Sachais, et al.
Blood|March 29, 2012
Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopeniaBruce S Sachais, Ann H Rux, Douglas B Cines, et al.
AIDS Research and Human Retroviruses|February 6, 2016
Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral AttachmentZahra F Parker, Ann H Rux, Amber M Riblett, et al.
The Journal of Biological Chemistry|October 8, 2013
Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4Rustem I Litvinov, Serge V Yarovoi, Lubica Rauova, et al.
Pageof 2